柳药集团
(603368)
| 流通市值：62.28亿 | | | 总市值：62.28亿 |
| 流通股本：3.97亿 | | | 总股本：3.97亿 |
| 利润表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 营业总收入 | 10,526,113,932.73 | 5,377,272,243.65 | 20,926,270,790.4 | 15,758,036,706.01 |
| 营业总成本 | 10,091,091,101.37 | 5,065,165,311.08 | 20,015,831,005.51 | 14,995,915,128.07 |
| 其他经营收益 | | | | |
| 营业利润 | 434,226,105.32 | 275,808,800.3 | 882,385,074.27 | 754,347,468.11 |
| 利润总额 | 425,386,783.4 | 273,142,798.85 | 869,941,726.73 | 748,512,238.63 |
| 净利润 | 371,359,675.49 | 225,454,168.92 | 720,536,392.03 | 653,956,241.67 |
| 每股收益 | | | | |
| 其他综合收益 | - | - | - | - |
| 综合收益总额 | 371,359,675.49 | 225,454,168.92 | 720,536,392.03 | 653,956,241.67 |
| 资产负债表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 流动资产: | | | | |
| 流动资产合计 | 17,658,123,505.54 | 17,888,527,587.92 | 18,426,676,239.07 | 18,254,424,698.93 |
| 非流动资产: | | | | |
| 非流动资产合计 | 2,947,993,808.02 | 2,929,735,019.25 | 2,911,389,588.72 | 2,929,476,645.23 |
| 资产总计 | 20,606,117,313.56 | 20,818,262,607.17 | 21,338,065,827.79 | 21,183,901,344.16 |
| 流动负债: | | | | |
| 流动负债合计 | 11,026,430,037.89 | 11,176,884,107.8 | 12,220,977,439.5 | 11,156,630,426.09 |
| 非流动负债: | | | | |
| 非流动负债合计 | 1,389,828,628.42 | 1,327,067,955.83 | 975,050,345.3 | 1,890,186,861.17 |
| 负债合计 | 12,416,258,666.31 | 12,503,952,063.63 | 13,196,027,784.8 | 13,046,817,287.26 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 7,880,336,018.88 | 8,006,108,912.94 | 7,828,896,148.07 | 7,824,897,722.61 |
| 股东权益合计 | 8,189,858,647.25 | 8,314,310,543.54 | 8,142,038,042.99 | 8,137,084,056.9 |
| 负债和股东权益合计 | 20,606,117,313.56 | 20,818,262,607.17 | 21,338,065,827.79 | 21,183,901,344.16 |
| 现金流量表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 11,440,203,663.45 | 5,411,428,806.02 | 24,173,987,512.87 | 17,966,940,066.34 |
| 经营活动现金流出小计 | 11,304,676,448.53 | 5,920,580,373.11 | 23,096,328,583.51 | 17,831,550,396.35 |
| 经营活动产生的现金流量净额 | 135,527,214.92 | -509,151,567.09 | 1,077,658,929.36 | 135,389,669.99 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 1,055,522,110.84 | 225,023,841.9 | 1,245,182,145.33 | 489,039,558.78 |
| 投资活动现金流出小计 | 951,092,383.68 | 374,637,444.02 | 1,747,027,537.45 | 1,090,653,512.49 |
| 投资活动产生的现金流量净额 | 104,429,727.16 | -149,613,602.12 | -501,845,392.12 | -601,613,953.71 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | 4,223,948,675 | 2,087,769,468.85 | 6,592,259,050.32 | 3,630,714,588.54 |
| 筹资活动现金流出小计 | 4,833,962,306.06 | 2,970,245,908.19 | 7,224,325,936.37 | 4,910,043,840.25 |
| 筹资活动产生的现金流量净额 | -610,013,631.06 | -882,476,439.34 | -632,066,886.05 | -1,279,329,251.71 |
| 汇率变动对现金及现金等价物的影响 | - | - | - | - |
| 现金及现金等价物净增加额 | -370,056,688.98 | -1,541,241,608.55 | -56,253,348.81 | -1,745,553,535.43 |
| 期末现金及现金等价物余额 | 2,972,251,026.43 | 1,801,066,106.86 | 3,342,307,715.41 | 1,653,007,528.79 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | -370,056,688.98 | - | -56,253,348.81 | - |
最新报告期：2026-08-28| 研究机构 | 分析师 | 预测每股收益(元) | 更新日 |
| 2026年 | 2027年 | 2028年 |
| 华泰证券 | 代雯,孔垂岩,王殷杰 | 1.71 | 1.78 | 1.88 | 2026-08-28 |